Evercore ISI lowered the firm’s price target on Ultragenyx (RARE) to $37 from $39 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RARE:
- Ultragenyx price target lowered to $50 from $60 at H.C. Wainwright
- Ultragenyx price target lowered to $45 from $50 at Citi
- Ultragenyx Earnings Call Balances Growth With Risk
- Ultragenyx Pharmaceutical Faces Lawsuit Following Clinical Trial Disclosures
- Ultragenyx price target lowered to $49 from $75 at TD Cowen